| Ytd | 378.18% | |
| 1y | 223.10% |
| Open | 85.68 | Prev Close | 84.72 | Low | 82.38 | High | 88.10 | Mkt Cap | 1.38B |
| Vol | 171.88K | Avg Vol | 292.05K | EPS | -15.41 | P/E | N/A | Forward P/E | 34.31 |
| Beta | 3.00 | Short Ratio | 5.16 | Inst. Own | 96.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 89.71 | 200-d Avg | 59.54 | 1yr Est | 115.83 |
AGL News
Here is how Agilon Health (AGL) and CRISPR Therapeutics AG (CRSP) have performed compared to their s
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering
Analysts upgraded Pentair, Agilon Health, Etsy, Radiant Logistics and Ulta Beauty, raising or settin
Analysts cut Exodus’ target, raised targets for Teledyne, Roblox, Scholar Rock, Zebra, Agilon, SM En
Bernstein analyst Lance Wilkes upgrades Agilon Health (NYSE:AGL) from Market Perform to Outperfor
JP Morgan analyst Lisa Gill maintains Agilon Health (NYSE:AGL) with a Underweight and raises the
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raise
Top Wall Street analysts upgraded various stocks, including BBY, BCE. See what other analysts think.
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and ra
Truist Securities analyst Jailendra Singh maintains Agilon Health (NYSE:AGL) with a Hold and rais
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and raises the pr
Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:AGL) with a In-Line a
Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Equal-Weight and raises the
Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.680 billion-$5.805 billion to $5.775 bi
Agilon Health (NYSE:AGL) reported quarterly earnings of $1.04 per share which beat the analyst conse
Top Wall Street analysts changed outlook on top names. See all rating changes on our analyst ratings
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Neutral to Sell and
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raise
Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb
These small-cap ETFs hold several Russell 2000 stocks that surged more than 400% in 2026, driven by
Micron Technology and Dell Technologies are the second- and third-best stocks in the S&P 500 thi
Barclays analyst Andrew Mok upgrades Agilon Health (NYSE:AGL) from Underweight to Equal-Weight an
Seven small-cap stocks rallied past 100% in May 2026 as first-quarter earnings reset risk appetite b
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the pr
Health care stocks flashing warning for momentum investors. RSI measures stock strength, overbought
Micron's 90% one-month rally has been the loudest story of the AI memory cycle. Ten Russell 2000
TD Cowen analyst Ryan Langston maintains Agilon Health (NYSE:AGL) with a Hold and raises the pric
AGL stock sees profit taking after soaring 100%. Agilon Health crushed Q1 estimates with $1.80 EPS a
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raise
The CNN Money Fear and Greed index declined but remained in the Greed zone on Thursday. US stocks fe
Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US
Wall Street analysts changed outlook on top names, downgraded Amplitude Inc, Accuray Inc, Angi Inc,
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Ana
Agilon Health shares surge after Q1 earnings beat, raised 2026 outlook, and stronger medical margins
U.S. stocks were mixed, Nasdaq up 150 points. Albemarle (ALB) rose 9.8% on strong earnings and raise
US stocks higher Thursday morning, Dow down 0.28%, Nasdaq up 0.50%, S&P 500 up 0.07%. Tech secto
Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:AGL) with a In-Line a
Jefferies analyst Jack Slevin upgrades Agilon Health (NYSE:AGL) from Hold to Buy and raises the p
Top Wall Street analysts changed their outlook on top names. See all rating changes, including upgra
Top analysts upgraded LPX, STNG, AGL, FTNT, SIGI & raised price targets. See other analysts'
Baird analyst Michael Halloran maintains Agilon Health (NYSE:AGL) with a Neutral and raises the p
Deutsche Bank analyst George Hill upgrades Agilon Health (NYSE:AGL) from Hold to Buy and raises t
Shares of Kulicke & Soffa Industries (NASDAQ: VECO) rose after beating earnings estimates. Other
Agilon Health (NYSE:AGL) raises FY2026 sales outlook from $5.410 billion-$5.580 billion to $5.680 bi
Agilon Health (NYSE:AGL) reported quarterly earnings of $1.80 per share which beat the analyst conse
JP Morgan analyst Lisa Gill downgrades Agilon Health (NYSE:AGL) from Neutral to Underweight and a